Pasar al contenido principal

GENERACION Y MODULACION DE LA RESPUESTA INMUNE ENTRENADA A LARGO PLAZO

PID2021-124328OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario ASOCIACION CENTRO DE INVESTIGACION COOP EN BIOCIENCIAS CIC BIOGUNE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Mitochondrial dysfunction promotes microbial composition that negatively impacts on ulcerative colitis development and progression

  • Peña Cearra, Ainize
  • Song, Deguang
  • Castelo, Janire
  • Palacios, Ainhoa
  • Lavín, José Luis
  • Azkargorta, Mikel
  • Elortza, Félix
  • Fuertes Franco, Miguel
  • Pascual Itoiz, Miguel Ángel
  • Barriales, Diego
  • Martín Ruiz, Itziar
  • Fullaondo, Asier
  • Aransay, Ana M.
  • Rodriguez, Héctor
  • Palm, Noah W.
  • Anguita, Juan
  • Abecia, Leticia
[EN] Recent evidence demonstrates potential links between mitochondrial dysfunction and inflammatory bowel diseases (IBD). In addition, bidirectional interactions between the intestinal microbiota and host mitochondria may modulate intestinal inflammation. We observed previously that mice deficient in the mitochondrial protein MCJ (Methylation-controlled J protein) exhibit increased susceptibility to DSS colitis. However, it is unclear whether this phenotype is primarily driven by MCJ−/− associated gut microbiota dysbiosis or by direct effects of MCJ-deficiency. Here, we demonstrate that fecal microbiota transplantation (FMT) from MCJdeficient into germ-free mice was sufficient to confer increased susceptibility to colitis. Therefore, an FMT experiment by cohousing was designed to alter MCJ-deficient microbiota. The phenotype resulting from complex I deficiency was reverted by FMT. In addition, we determined the protein expression pathways impacted by MCJ deficiency, providing insight into the pathophysiology of IBD. Further, we used magnetic activated cell sorting (MACS) and 16S rRNA gene sequencing to characterize taxa-specific coating of the intestinal microbiota with Immunoglobulin A (IgA-SEQ) in MCJ-deficient mice. We show that high IgA coating of fecal bacteria observed in MCJ-deficient mice play a potential role in disease progression. This study allowed us to identify potential microbial signatures in feces associated with complex I deficiency and disease progression. This research highlights the importance of finding microbial biomarkers, which might serve as predictors, permitting the stratification of ulcerative colitis (UC) patients into distinct clinical entities of the UC spectrum., SI, We thank Estibaliz Atondo for her technical support. We thank MCIN/AEI/10.13039/501100011033 (PID2021-124328OB-I00 -to JA- and CEX2021-001136-S -Severo Ochoa Center of Excellence to CIC bioGUNE). A.P.C. was a fellow at the University of the Basque Country (UPV/EHU) and is currently a postdoctoral fellow funded by the Basque Government. CIC bioGUNE support was provided by the Basque Department of Industry, Tourism and Trade (Etortek and Elkartek Programs), and the Innovation Technology Department of the Bizkaia County.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Mitochondrial Dysfunction: Unraveling the Elusive Biology Behind Anti-TNF Response During Ulcerative Colitis

  • Kioroglou, Dimitrios
  • Peña Cearra, Ainize
  • Corraliza, Ana M.
  • Seoane, Iratxe
  • Castelo, Janire
  • Panés, Julian
  • Gómez Irwin, Laura
  • Rodríguez Lago, Iago
  • Ortiz de Zárate, Jone
  • Fuertes Franco, Miguel
  • Martín Ruiz, Itziar
  • González, Monika
  • Aransay, Ana M.
  • Salas, Azucena
  • Rodriguez, Héctor
  • Anguita, Juan
  • Abecia, Leticia
  • Marigorta, Urko M.
[EN]Background: Recent studies hint at mitochondrial genes influencing UC patient response to anti-TNF treatment. We evaluated this hypothesis by following a targeted strategy to identify gene expression that captures the relationship between mitochondrial dysregulation and response to treatment. Our objective was to initially examine this relationship in colon samples and subsequently assess whether the resulting signal persists in the bloodstream. Methods: We analyzed the transcriptome of colon samples from an anti-TNF-treated murine model characterized by impaired mitochondrial activity and treatment resistance. We then transferred the findings that linked mitochondrial dysfunction and compromised treatment response to an anti-TNF-treated UC human cohort. We next matched differential expression in the blood using monocytes from the peripheral blood of controls and IBD patients, and we evaluated a classification process at baseline with whole blood samples from UC patients. Results: In human colon samples, the derived gene set from the murine model showed differential expression, primarily enriched metabolic pathways, and exhibited similar classification capacity as genes enriching inflammatory pathways. Moreover, the evaluation of the classification signal using blood samples from UC patients at baseline highlighted the involvement of mitochondrial homeostasis in treatment response. Conclusions: Our results highlight the involvement of metabolic pathways and mitochondrial homeostasis in determining treatment response and their ability to provide promising classification signals with detection levels in both the colon and the bloodstream., NO, This work was supported by grants from the Spanish Ministry of Science MCIN/AEI/10.13039/501100011033 (PID2019-108244RA-I00 to UMM, PID2021-124328OB-I00 to J.A., RYC2020-030632-I to U.M.M, CEX2021-001136-S to U.M.M and D.K),”La Caixa” Foundation (ID 100010434, fellowship code LCF/BQ/LI18/11630001 to U.M.M), V Grant from GETECCU-MSD (Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis ulcerosa to L.A.). A.P.C. and I.S. are supported by fellowships from the University of the Basque Country (UPV/EHU) and the Basque Government, respectively.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The microbiota metabolite, phloroglucinol, confers long-term protection against inflammation

  • Castelo, Janire
  • Araujo-Aris, Sarai
  • Barriales, Diego
  • Tanner Pasco, Samuel
  • Seoane, Iratxe
  • Peña-Cearra, Ainize
  • Palacios, Ainhoa
  • Simó, Carolina
  • García-Cañas, Virginia
  • Khamwong, Muthita
  • Martín-Ruiz, Itziar
  • Gonzalez-Lopez, Monika
  • Bárcena, Laura
  • Martín Rodríguez, José Ezequiel
  • Lavín, José Luís
  • Gutiez, Naiara
  • Marcos-Fernández, Raquel
  • Atondo, Estíbaliz
  • Cobela, Arantza
  • Plaza-Vinuesa, Laura
  • Plata, Adrián
  • Santos-Fernandez, Eneko
  • Fernandez-Tejada, Alberto
  • Villarán, Mari Carmen
  • Mancheño, Jose M.
  • Maria Flores, Juana
  • María Aransay, Ana
  • Pellón, Aize
  • De Las Rivas, Blanca
  • Muñoz, Rosario
  • Margolles Barros, Abelardo
  • Ruas-Madiedo, Patricia
  • Victoria Selma, Maria
  • Gomez de Agüero, Mercedes
  • Abecia, Leticia
  • Anguita, Juan
  • Rodríguez, Héctor
Phloroglucinol is a key byproduct of gut microbial metabolism that has been widely used as a treatment for irritable bowel syndrome. Here, we demonstrate that phloroglucinol tempers macrophage responses to pro-inflammatory pathogens and stimuli. In vivo, phloroglucinol administration decreases gut and extraintestinal inflammation in murine models of inflammatory bowel disease and systemic infection. The metabolite induces modest modifications in the microbiota. However, the presence of an active microbiota is required to preserve its anti-inflammatory activity. Remarkably, the protective effect of phloroglucinol lasts partially at least 6 months. Single-cell transcriptomic analysis of bone marrow progenitors demonstrates the capacity of the metabolite to induce long-lasting innate immune training in hematopoietic lineages, at least partially through the participation of the receptor and transcription factor, aryl hydrocarbon receptor (AhR). Phloroglucinol induces alterations in metabolic and epigenetic pathways that are most prevalent in upstream progenitors as hallmarks of central trained immunity. These data identify phloroglucinol as a dietary-derived compound capable of inducing central trained immunity and modulating the response of the host to inflammatory insults., This work was supported by MCIN/AEI/10.13039/501100011033(PID2021-124328OB-100 to JA, AGL2017-86757-R and RYC-2013-13666 to LA, SAF2015-73549-JIN to HR, PID2020-117911RB-100 to AFT). MGA is funded by the DeutscheForschungsgemeinschaft (DFG, German researchFoundation) – SFB 1583/1 [Project number: 492620490] andSPP 2330 [Project number: 465341196]. Supported in part byFundación Jesús de Gangoiti and by fellowships from Getteccu(Geteccu-MSD to HR and LA, and Geteccu-FreseniusKabi to JA).CIC bioGUNE is the recipient of a Severo Ochoa Centro deExcelencia award [CEX2021-001136-S].JC was partly supported18 J. CASTELO ET AL. by a FEMS Research and Training Grant [1816] and an EMBOScientific Exchange Grant [9792]. APa and IS were supported bya predoctoral fellowship from the Basque Government. APe wassupported by a postdoctoral fellowship from the BasqueGovernment. DB [BES-2016-078437], SAA [PRE-2019-091720],APl [PRE2018-085772] and ESF [PRE2022-104669] were recipi-ents of MCIU FPI fellowships from MCIN/AEI/10.13039/501100011033. APC was a recipient of a fellowship from theUniversity of the Basque Country. NG held a predoctoral grantfrom the Scientific Foundation of the Spanish AssociationAgainst Cancer in Biscay [PRDVZ222452GUTI]. We thank theBasque Department of Industry, Tourism and Trade (Etortek andElkartek programs) and the Innovation Technology Departmentof the Bizkaia Province. This project has received funding fromthe European Union’s Horizon 2020 research and innovationprogramme under the Marie Skłodowska-Curie grant agreementNº 860325 to STP and JA., Peer reviewed